Neos Therapeutics Inc (NEOS) Quote

Is it?

It has gone back to the old bid/ask now. Sorry bout that.

I'm using realtime thru. TD ameritrade..... current bid 1.18 and current ask 1.19 at 5:05pm

I'm using this free tool.

https://markets.cboe.com/us/equities/market_statistics/book/NEOS/

On td ameritrade I'm seeking 1.16 bid and 1.17 ask for after hrs...what platform are you looking at?

What's up with the Level II, no buyers, sellers are now $1.59-$1.70
Must be something up...

* * $NEOS Video Chart 03-18-2021 * *

Link to Video - click here to watch the technical chart video

Yawn. Ever looked at any "biotech" companies? Especially ones in relatively early stages of existence? At least NEOS has some decent revenue for being so young.

Lol and yet its still up today my my imo

Huge debt $43,950,0000 Million and Book value per share -($0.41)

Profitability
Profit Margin -38.35%
Operating Margin (ttm) -23.50%

Management Effectiveness
Return on Assets (ttm) -10.71%


Income Statement
Quarterly Revenue Growth (yoy) -28.50%

EBITDA -9.69M
Net Income Avi to Common (ttm) $-21.86M
Diluted EPS (ttm) -0.4390


Balance Sheet
Total Debt (mrq) 43.95M

Book Value Per Share (mrq) -0.41

Cash Flow Statement
Operating Cash Flow (ttm) -6.41M

Just remember it is a delinquent stock according to Schwab

$NEOS. Im sorry but numbers dont lie. 1st Vol PM. Merger news. Either way its a runner. Merger passes shorts cover. Why? And no more shares to short. That equals $$$! https://t.co/fn5NvlLNMY

$NEOS is screaming for the top as investors await the results of a special meeting surrounding a potential merger with AYTU. https://cnafinance.com/neos-stock-neos-therapeutics-climbs-on-merger-hopes/

* * $NEOS Video Chart 03-16-2021 * *

Link to Video - click here to watch the technical chart video

* * $NEOS Video Chart 01-20-2021 * *

Link to Video - click here to watch the technical chart video

That's .94 per share for $NEOS shareholders... at .63, this can only be seen as a BUY here...

The 10K said that NEOS stockholders would receive.1088 of AYTU stockbased on December 8. AYTU opened at 8.80 and closed at 8.70. Is it the .1088 based on opening or the average of the open and close? What would the actual pps be? Also the 10K will terminate on September 10 if merger isn’t completed and the lawsuit might delay the merger to the termination date.

Dec-12-20 08:58AM INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Companies; Shareholders are Encouraged to Contact the Firm CPAH, MTSC, NEOS, ZAGG
GlobeNewswire

Dec-11-20 11:41AM
NEOS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of NEOS and Encourages Investors to Contact the Firm
GlobeNewswire -15.28%
10:38AM
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Neos Therapeutics, Inc. Merger
GlobeNewswire

Dec-10-20 07:35PM

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Neos Therapeutics, Inc.
PR Newswire +47.68%
07:03PM

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Neos Therapeutics, Inc. (Nasdaq - NEOS)
ACCESSWIRE
04:52PM

SHAREHOLDER ALERT: WeissLaw LLP Investigates Neos Therapeutics, Inc.
PR Newswire
10:31AM

Neos Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Neos Therapeutics, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm NEOS

Healight Platform Technology

For inquiries regarding the Healight Platform Technology, please email COVID-19@aytubio.com.
https://aytubio.com/healight/

Aytu BioScience Announces Manufacture and Delivery of Healight(TM) Devices for Use in COVID-19 Clinical Study

Aug 17, 2020
https://www.biospace.com/article/releases/aytu-bioscience-announces-manufacture-and-delivery-of-healight-tm-devices-for-use-in-covid-19-clinical-study/

Aytu BioScience Announces Manufacture and Delivery of Healight(TM) Devices for Use in COVID-19 Clinical Study
Delivery of Investigational Endotracheal Ultraviolet-A Light Catheter Devices Enables Near-Term Initiation of Planned Clinical Studies in Severely Ill COVID-19 Patients
August 17, 2020
https://www.yahoo.com/news/aytu-bioscience-announces-manufacture-delivery-120000160.html


Aytu BioScience announced on April 20, four days before the Trump remarks, that it has signed an exclusive licensing deal with Cedars-Sinai Medical Center in Los Angeles. The center has developed and is testing a UV-A “Healight” designed to be inserted via a catheter inside the trachea to kill pathogens, including the coronavirus.

Ultraviolet, or UV, light is commonly used by physicians to treat skin diseases. Cedars-Sinai says UV-A phototherapy potentially could be employed in internal organs.

This prompted Mr. Trump to say, “I see the disinfectant where it knocks it out in a minute. One minute. And is there a way we can do something like that by injection inside or, or almost a cleaning?”

April 26, 2020
https://www.washingtontimes.com/news/2020/apr/26/pharmaceutical-firm-aytu-bioscience-testing-uv-lig/

the Neos brands are on a strong growth trajectory.”

Aytu’s existing portfolio includes a nasal testosterone spray for men, a spray sleep aid and a 12-hour codeine-based cough syrup. Its pediatric products range from antibiotics and allergy medication to supplements for infants and children with fluoride deficiency.

It also distributes COVID-19 rapid antibody and antigen tests, and recently licensed rights to develop an ultraviolet medical device as a treatment for the coronavirus and other respiratory infections. In addition, Aytu operates a consumer health subsidiary, Innovus Pharmaceuticals Inc., that develops and sells men’s and women’s health and vitality products direct to consumers.


Dec 10, 2020
https://www.dallasnews.com/business/health-care/2020/12/10/grand-prairie-based-neos-therapeutics-is-merging-with-a-colorado-specialty-pharma-company/

Neos Therapeutics Inc. is based out of Grand Prairie, TX and has some 213 employees. Its CEO is Gerald McLaughlin.

Neos Therapeutics Inc is a pharmaceutical company, engaged in the development, manufacture, and commercialization of products for the treatment of attention deficit hyperactivity disorder (ADHD) using its drug delivery technologies

https://www.equities.com/news/neos-therapeutics-inc-neos-plunges-15-28-on-december-11

Neos will merge with a wholly owned subsidiary of Aytu in an all-stock transaction.


Expanding into ADHD with Neos is the ideal embodiment of Aytu’s strategy to build a portfolio of best-in-class prescription therapeutics and consumer health products competing in large markets.”


The Merger is currently expected to close by the second quarter of 2021, subject to certain approvals by both Aytu and Neos stockholders and the satisfaction of other customary closing conditions.

December 10, 2020,
https://finance.yahoo.com/news/aytu-bioscience-neos-therapeutics-announce-130000608.html


___________________________________________________________________

NEOS, Buy, Sell or Hold? PPS targets? anyone. It all sounds like NEOS stock could go up in value..??
_________________________________________________________________

WIDGETS production ?

https://aytubio.com/products/marketed-products/


COVID-19 IgG/IgM Rapid Test
https://aytubio.com/covid-19/

Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement, Creating a Combined $100M Revenue(1) Specialty Pharmaceutical Company
ENGLEWOOD, CO and GRAND PRAIRIE, TX / ACCESSWIRE / December 10, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, and Neos Therapeutics, Inc. (NASDAQ:NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today announced that...

Dec 10, 2020
https://irdirect.net/AYTU/press_releases?template=aytu&years_pagination=1&per_page=10

https://aytubio.com/ https://aytubio.com/covid-19/

...Aytu also distributes a COVID-19 IgG/IgM rapid antibody test and rapid antigen test. These tests are used separately in the rapid, qualitative diagnostic assessment of the 2019 Novel Coronavirus. Additionally, Aytu recently licensed worldwide rights to develop the Healight™ technology platform. Healight is an investigational medical device being studied as a prospective treatment for COVID-19 and other respiratory infections....
December 10, 2020
https://irdirect.net/prviewer/release_only/id/4562900

Apr-17-20 09:37AM
Aytu BioScience Investigated for Possible Securities Laws Violations; Investors Who Lost Money Should Contact Block & Leviton
GlobeNewswire -8.00%
08:25AM
Aytu BioScience Confirms Export and Incoming Delivery of COVID-19 IgG/IgM Rapid Tests
ACCESSWIRE
Apr-16-20 08:00AM
Aytu BioScience Announces Positive Results from an Independently Conducted Clinical Study of the Company's Licensed COVID-19 IgG/IgM Point-of-Care Rapid Test
ACCESSWIRE
Apr-15-20 05:45PM
Aytu Bioscience, Inc. (AYTU) Stock Moves -1.27%: What You Should Know
Zacks
08:00AM
Aytu BioScience Provides Update on its Licensed COVID-19 IgG/IgM Rapid Test Supply and Ongoing U.S. Distribution
ACCESSWIRE
Apr-14-20 12:00PM
Aytu Bioscience, Inc. (AYTU) Upgraded to Strong Buy: What Does It Mean for the Stock?
Zacks +12.95%
Apr-13-20 08:00AM
Aytu BioScience Consumer Health Subsidiary Launches Regoxidine(R), an FDA Approved Hair Regrowth Treatment Foam that Contains 5% Minoxidil and Targets Over 11 Million U.S. Consumers Who Purchased Hair Regrowth Products in 2019
ACCESSWIRE
Apr-09-20 08:00AM
Aytu BioScience Announces Updated Annual Shareholder Meeting Date and Virtual Room Access
ACCESSWIRE -5.92%
Apr-08-20 05:45PM
Aytu Bioscience, Inc. (AYTU) Stock Sinks As Market Gains: What You Should Know
Zacks
04:24PM
Edited Transcript of AYTU earnings conference call or presentation 13-Feb-20 9:30pm GMT
Thomson Reuters StreetEvents
08:00AM
Aytu BioScience Announces Exclusive ZolpiMist(TM) License to Commercialize Aytu's Oral Spray Sleep Aid in South Korea
ACCESSWIRE
Apr-07-20 08:00AM
Aytu BioScience Receives $23.0 Million from Warrant Exercises
ACCESSWIRE
Apr-06-20 08:00AM
Aytu Featured on NBC and Fox News (VIDEO): "Denver officers, firefighters will be among first in US to get rapid COVID-19 tests"; "Denver scores 2,700 COVID-19 rapid tests for first responders"
ACCESSWIRE
Apr-03-20 09:37AM
Top Ranked Momentum Stocks to Buy for April 3rd
Zacks
09:15AM
XpresSpa Pursues Novel Coronavirus (COVID-19) Screening and Testing at U.S. Airports
GlobeNewswire
08:00AM
Aytu BioScience Announces First Commercial Shipment of its 2-10 Minute COVID-19 IgG/IgM Point-of-Care Rapid Test
ACCESSWIRE
Apr-02-20 11:33AM
Top Ranked Momentum Stocks to Buy for April 2nd
Zacks
Apr-01-20 08:00AM
Aytu BioScience Announces Receipt of Initial Shipment of 100,000 COVID-19 IgG/IgM Point-of-Care Rapid Tests; Additional 500,000 Tests on Order
ACCESSWIRE
Mar-30-20 11:30AM
Has Aytu Bioscience (AYTU) Outpaced Other Medical Stocks This Year?
Zacks -7.69%
08:00AM
AYTU Announces Delay of Annual Meeting of Stockholders Due to Colorado's "Shelter in Place" Order Related to the COVID-19 Crisis
ACCESSWIRE
Mar-25-20 09:08AM
Aytu BioScience (AYTU) in Focus: Stock Moves 6.4% Higher
Zacks -15.58%
08:00AM
Aytu BioScience Regains Compliance with NASDAQ Minimum Bid Price Requirement
ACCESSWIRE
Mar-24-20 01:15PM
Aytu BioScience to Issue Coronavirus Rapid Test in North America
Zacks +6.42%
07:43AM
The Zacks Analyst Blog Highlights: Danaher, Quidel, Aytu BioScience, QIAGEN and Co-Diagnostics
Zacks
Mar-23-20 09:48AM
FDA Gives Aytu OK To Distribute Rapid COVID-19 Test, Company Expects To Receive 100,000 Tests This Week
Benzinga +37.50%
08:00AM
Aytu BioScience Submits Notice of Commercialization to the FDA, Allowing for Company's Distribution of its 2-10 Minute COVID-19 IgG/IgM Point-of-Care Rapid Test
ACCESSWIRE

* * $NEOS Video Chart 12-10-2020 * *

Link to Video - click here to watch the technical chart video

hows still buying this

My price target is $2.14.<<<NEOS..TY for your response..Where do you this number from?

Great news. Thanks for sharing.

This should be up 100% or better today.. Will see if it gets there

No worries it will get better MMs just doing their thing cleaning up the stop losses..
My NEOS investment is finally paying off plus up almost 60% with this news today..

GO NEOS!!!

I entered this morning, as well.

My price target is $2.14.

$NEOS..I got in this morning but havnt really done proper DD Just saw the merger and the premarket spike so here I am..Whats everyone idea of FMV here?

idk was wondering the same thing .. was nice merger news for NEOS shareholders .. profit takers?

Why the drop

NEOS pretty nice merger news https://finance.yahoo.com/news/aytu-bioscience-neos-therapeutics-announce-110100289.html

Up nicely premarket.

Looks like another great day ahead.

Thanks. Good article.

I read someplace today that our ADHD drug is now selling more than Pfizer's drug. That is a big deal ADHD is a major problem.

Great day today.

Hopefully, we see many more.

* * $NEOS Video Chart 10-21-2020 * *

Link to Video - click here to watch the technical chart video

Breaking News: $NEOS What Are Best Penny Stocks Right Now? 3 To Watch Before Friday

Are These At The Top Of Your Watch List This Week? Penny stocks remain one of the high points in the stock market today. After a huge breakout yesterday from WEI and previous to that, KXIN, there’s definitely a fervor for small-cap stocks right now. But there are more tha...

Read the whole news NEOS - What Are Best Penny Stocks Right Now? 3 To Watch Before Friday

About to explode again

Thanks. Have been following this

for quite some time. Finally got in yesterday and doubled up this AM. Chart is looking good - hope it continues.

https://finance.yahoo.com/news/3-penny-stocks-massive-upside-193058024.html

NEOS an Outperform (i.e. Buy) along with an $8 price target.

“Adzenys XR-ODT has experienced impressive prescription growth over the course of the past year, and is now the preferred ADHD alternative dosage form taking over from Pfizer's market-leading Quillivant XR as its new-to-brand market share reached the number 1 position.”

https://www.neostx.com/microparticle-delivery-technology/partnering-with-us/

Thanks. EOM.

I also read an article with a target price of $8.33 that's 1600% if it pans out

Well, let's see what happens.

Estimates for next Qtr. are very good.

Yes been holding seems like forever